# Advisor Review - GPT-5-mini

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5-mini
**Paper:** paper.pdf
**Timestamp:** 2026-02-03T23:38:40.544656
**Route:** OpenRouter + LaTeX
**Tokens:** 17224 in / 2347 out
**Response SHA256:** 608e06ad3e69a8ee

---

I checked the LaTeX source carefully for the specific classes of fatal errors you asked me to screen for. I focused only on the four mandated categories (Data-Design Alignment, Regression Sanity, Completeness, Internal Consistency) and did not comment on prose, contribution, or minor choices.

Summary: I found no fatal errors.

Notes on what I checked and why I judged each category to pass

1) Data–Design Alignment
- Treatment timing vs. data coverage: The paper reports ACS PUMS 2017–2019, 2021–2024 (2020 excluded). The latest treatment cohorts the paper analyzes are 2024 adopters; the paper explicitly treats two states as adopting in 2025 (Idaho, Iowa) and uses them as controls. Thus max(treatment year) ≤ max(data year (2024)) holds. The event-time mapping table and narrative are consistent with this coding (cohorts 2021–2024 mapped to event times through 2024).
- Post-treatment observations: For cohorts adopted in 2021–2023 the paper has post-treatment years in the ACS through 2024 (event times up to e=2 for many cohorts). For 2024 adopters the paper correctly notes only e=0 is observed in 2024. The paper acknowledges limited post-treatment horizon for some cohorts (e.g., only 4 states in 2021 cohort at e=3), and does not claim unavailable post-treatment data.
- Treatment definition consistency: The narrative, the event-time mapping table (tab:timing_map), and the Treatment Assignment subsection all use the same rule (treated in year t if effective date ≤ July 1 of t), and the cohorts described in text match the table and later use (e.g., 4 states in 2021 cohort, 25 in 2022, 13 in 2023, 5 in 2024, controls AR/WI/ID/IA). I found no contradiction between the description and the treatment variable coding as described.

2) Regression Sanity
- I inspected all reported summary regression numbers appearing in the text (ATTs, standard errors, event-study descriptions, DDD coefficients, etc.). The reported coefficients and standard errors are numerically plausible for the outcomes studied (percentage point units). None of the following red flags appears in the visible reported results: no SEs or coefficients are absurdly large (e.g., SEs >1000 or coefficients >100), no negative standard errors are reported, and no R² values outside [0,1] are mentioned. Example reported values: ATT = −0.5 pp (SE = 0.7 pp), post-PHE ATT = −2.18 pp (SE = 0.76 pp), DDD CS-DiD = +1.0 pp (SE = 1.5 pp) — all internally plausible.
- The paper explicitly reports cluster-robust SEs and supplements with wild-cluster bootstrap; no missing SEs are evident in the narrative. I therefore did not find any regression-sanity level fatal errors in the reported numeric output.

3) Completeness
- I looked for placeholder markers (NA, TBD, TODO, PLACEHOLDER, XXX) in the main text; none appear.
- The LaTeX source uses \input{tables/...} for several tables and includes figures, but the manuscript text consistently refers to tables and figures and reports numeric results (i.e., main regression results and sample sizes are reported in the text). The Data Appendix includes a sample-size-by-year table with complete numbers that sum consistently to the totals reported elsewhere (total postpartum = 237,365; low-income postpartum total = 86,991). I did not see explicit missing essential elements in the text: sample sizes are reported, SEs are shown in text, and references to tables/figures are present and numbered.
- Caveat (not a fatal error): the LaTeX uses external \input files for regression tables (tab1_summary, tab2_main_results, tab3_robustness, tab5_heterogeneity, tab4_adoption). I could not inspect the content of those files in this review because they are external to the main .tex file shown. That alone is not a fatal error if those files actually exist and contain full table entries; it would be a fatal completeness error only if those files were missing or contained placeholders. Based on the internal consistency of numbers reported in the main text and the Data Appendix sample-size table, there is no evidence in the provided source of placeholders or empty/missing numeric entries.

4) Internal Consistency
- Numbers match across places where they are reported: the total sample (237,365) is consistent in Abstract, Introduction, Data section, and Appendix sample-size table totals. Low-income postpartum totals match between the Sample Construction subsection and the Appendix table (86,991). The event-time mapping table matches cohort descriptions in the Treatment Assignment subsection. Reported ATT and SE values are consistent where repeated.
- Timing consistency: the sample periods, PHE window (March 2020–May 2023), and the years used for pre/post specifications are described consistently across sections. The paper repeatedly notes that 2023 is a mixed year due to PHE ending in May 2023 and explicitly reports sensitivity analyses excluding 2023; that internal caveat is consistently applied.

Conclusion
- I found no fatal errors in the four critical categories you asked me to check. I did not find any contradictions between treatment timing and the data years, no obviously broken regression outputs in the numbers reported, no explicit placeholders or missing essential elements in the visible source, and no internal inconsistencies between text, tables, and appendix numbers.

Final verdict
ADVISOR VERDICT: PASS